Provided by Tiger Trade Technology Pte. Ltd.

Fidelity MSCI Health Care Index ETF

85.01
+0.40000.47%
Post-market: 85.100.0900+0.11%19:30 EDT
Volume:221.54K
Turnover:18.83M
Market Cap:3.55B
PE:- -
High:85.25
Open:84.62
Low:84.54
Close:84.61
52wk High:85.46
52wk Low:64.30
Shares:41.75M
Float Shares:41.75M
Volume Ratio:1.03
T/O Rate:0.53%
Dividend:1.02
Dividend Rate:1.20%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Broadcom Stock Headlines 3 Cash Flow Picks Trading Below Fair Value

Simply Wall St.
·
Aug 22

Johnson & Johnson, AbbVie, Chevron, Energy Transfer, Home Depot Shaken

TIPRANKS
·
Aug 22

Moderna, ADI, Merck, EPR, TJX: Trending With Analysts

TIPRANKS
·
Aug 22

How a Big Bet on Cancer Vaccines Brought Moderna Back from the Brink

Dow Jones
·
Aug 22

Top Stock Market Highlights of the Week: Sembcorp Industries, Singapore’s Big Three Banks, Moderna and CapitaLand Investment

The Smart Investor
·
Aug 22

Soon You Can Buy Medicare Advantage Plans at Costco. What You Need to Know.

Dow Jones
·
Aug 22

Novavax Inc. Stock Rises 6.2%, Outperforms Peers

Dow Jones
·
Aug 22

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 22

Johnson & Johnson Names New Vice President for Litigation

Reuters
·
Aug 22

Stocks Ex-Dividend August 25

Dow Jones
·
Aug 22

Goldman Sachs, Merck Share Gains Contribute to Dow's 500-Point Jump

Dow Jones
·
Aug 22

US Equity Indexes Lower This Week as Trump Threatens Major Economic War on Iran

MT Newswires Live
·
Aug 22

Merck Price Target Raised to $160.00/Share from $140.00 by Goldman Sachs

Dow Jones
·
Aug 22

UnitedHealth Group (UNH) Stock Looks Cheap On Value But Faces Risk On News

Simply Wall St.
·
Aug 22

AbbVie Expands Aesthetics Pipeline With New Phase 2 Forehead Lines Study

TIPRANKS
·
Aug 22

Eli Lilly Targets Ramadan Diabetes Market With New Orforglipron Trial

TIPRANKS
·
Aug 22

AbbVie Targets Pediatric Alopecia With New Phase 3 Trial: What Investors Should Watch

TIPRANKS
·
Aug 22

Eli Lilly’s Dulaglutide Study Sheds Light on Fasting Risks and Diabetes Care

TIPRANKS
·
Aug 22

AbbVie’s Emraclidine Schizophrenia Study Ends Early: What Investors Need to Know Now

TIPRANKS
·
Aug 22

Three Scientists Beat J&J's Defamation Suit over Talc Research

Reuters
·
Aug 22